Novartis buys Ebner's Roche stake as CFO (Chief Financial Officer) departs
This article was originally published in Clinica
Executive Summary
Novartis has bought holdings in pharmaceuticals and diagnostics group Roche which were owned by BZ Group Holdings, a Swiss financial group owned by Martin Ebner. The rival Swiss drugs company paid SFr4.83 billion ($2.77 billion) The acquisition of 20% of bearer shares available does not change the majority holding of voting shares owned by family interests descending from the founder of the group Fritz Hoffmann-La Roche.